Idiopathic pulmonary fibrosis will increase the risk of lung cancer
- PMID: 25189961
Idiopathic pulmonary fibrosis will increase the risk of lung cancer
Abstract
Objective: To review the studies investigating the increased risk of lung cancer in patients with idiopathic pulmonary fibrosis (IPF).
Data sources: Data cited in this review were obtained mainly from PubMed and Medline from 1999 to 2013 and highly regarded older publications were also included.
Study selection: We identified, retrieved and reviewed the information on the frequency, risk factors, anatomical features, histological types, clinical manifestations, computed tomography findings and underlying mechanisms of lung cancer in IPF patients.
Results: The prevalence rates of lung cancer in patients with IPF (4.8% to 48%) are much higher than patients without IPF (2.0% to 6.4%). The risk factors for lung cancer in IPF include smoking, male gender, and age. Lung cancers often occur in the peripheral lung zones where fibrotic changes are predominant. Adenocarcinoma and squamous cell carcinoma are the most common types of lung cancer in patients with IPF. Radiologic features of these patients include peripherally located, ill-defined mass mimicking air-space disease. The underlying mechanisms of the development of lung cancer in patients with IPF have not been fully understood, but may include the inflammatory response, epithelial injury and/or abnormalities, aberrant fibroblast proliferation, epigenetic and genetic changes, reduced cell-to-cell communication, and activation of specific signaling pathways.
Conclusions: These findings suggest that IPF is associated with increased lung cancer risk. It is necessary to raise the awareness of lung cancer risk in IPF patients among physicians and patients.
Similar articles
-
Incidence and radiologic-pathological features of lung cancer in idiopathic pulmonary fibrosis.Clin Respir J. 2018 Apr;12(4):1700-1705. doi: 10.1111/crj.12732. Epub 2017 Dec 18. Clin Respir J. 2018. PMID: 29094803
-
Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.Respir Med. 2014 Oct;108(10):1549-55. doi: 10.1016/j.rmed.2014.07.020. Epub 2014 Aug 15. Respir Med. 2014. PMID: 25175479
-
Cumulative incidence of and predictive factors for lung cancer in IPF.Respirology. 2009 Jul;14(5):723-8. doi: 10.1111/j.1440-1843.2009.01547.x. Respirology. 2009. PMID: 19659650
-
Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update.Curr Opin Pulm Med. 2015 Nov;21(6):626-33. doi: 10.1097/MCP.0000000000000217. Curr Opin Pulm Med. 2015. PMID: 26390339 Review.
-
Lung cancer in patients with idiopathic pulmonary fibrosis.Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Pulm Pharmacol Ther. 2017. PMID: 28377145 Review.
Cited by
-
Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth.Neoplasia. 2017 Jun;19(6):496-508. doi: 10.1016/j.neo.2017.04.004. Epub 2017 May 11. Neoplasia. 2017. PMID: 28501760 Free PMC article.
-
Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.In Vivo. 2017 Jul-Aug;31(4):773-777. doi: 10.21873/invivo.11130. In Vivo. 2017. PMID: 28652456 Free PMC article.
-
Lung nodule malignancy classification with associated pulmonary fibrosis using 3D attention-gated convolutional network with CT scans.J Transl Med. 2024 Jan 13;22(1):51. doi: 10.1186/s12967-023-04798-w. J Transl Med. 2024. PMID: 38216992 Free PMC article.
-
Incidentally Detected Malignancies in Lung Transplant Explants.Transplant Direct. 2019 Oct 8;5(11):e503. doi: 10.1097/TXD.0000000000000947. eCollection 2019 Nov. Transplant Direct. 2019. PMID: 31773056 Free PMC article.
-
Lung Cancer and Interstitial Lung Diseases.Cancers (Basel). 2024 Aug 13;16(16):2837. doi: 10.3390/cancers16162837. Cancers (Basel). 2024. PMID: 39199608 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical